Swine Vaccines Market Analysis

Swine Vaccines Market Analysis

To get key market trends

  Download Free Sample

Based on product, the market is segmented into inactivated vaccines, live attenuated vaccines, recombinant vaccines, subunit vaccines, toxoid vaccines, and other products. The inactivated vaccines segment accounted for USD 568.4 million in 2023 in the global market.
 

• The proven track record of inactivated vaccines in preventing diseases like porcine reproductive and respiratory syndrome, swine influenza, erysipelas, foot-and-mouth disease among others contributes to their widespread acceptance and trust among farmers and veterinarians.
   
• Additionally, inactivated vaccines tend to cause fewer side effects and adverse reactions, increasing their acceptance and further contributing to their dominant market share.
   

Based on disease type, the swine vaccines market is classified into porcine reproductive and respiratory syndrome (PRRS), porcine circovirus type 2 (PCV2), mycoplasma hyopneumoniae, classical swine fever (CSF), swine influenza, erysipelas, foot-and-mouth disease (FMD), African swine fever (ASF), porcine parvovirus, and other disease types. The porcine reproductive and respiratory syndrome (PRRS) segment held highest market share of 17.8% in 2023.
 

• PRRS is one of the most widespread and economically damaging diseases affecting swine herds globally. Its high prevalence necessitates effective vaccination programs to control and prevent outbreaks, driving significant demand for PRRS vaccines.
   
• PRRS severely affects pig productivity, causing issues like abortions in pregnant sows, stillbirths, and weak piglets. Vaccination is essential to maintain herd health and productivity, ensuring consistent and high-quality pork production.
   
• These factors collectively aid in driving the growth of porcine reproductive and respiratory syndrome segment in market.
   

Based on end-user, the swine vaccines market is categorized into veterinary hospitals & clinics, swine farms, and research institutes. The veterinary hospitals & clinics segment dominated the global market and is poised to grow at 5% CAGR.
 

• Veterinary hospitals and clinics hold the highest market share in the swine vaccine market due to their professional expertise and trust. Farmers and swine producers rely on veterinarians for effective disease management and prevention, ensuring high vaccine uptake.
   
• These facilities have access to the latest and most advanced vaccines, ensuring swine are protected against emerging and evolving diseases. The ability to provide cutting-edge vaccination solutions enhances the appeal of veterinary hospitals and clinics as primary vaccination providers, driving segment growth.
   

In 2023, the North American swine vaccines market was valued at USD 633.6 million and is expected to grow at a CAGR of 5.1% from 2024 to 2032.
 

• North America boasts advanced veterinary infrastructure, including well-equipped hospitals, clinics, and research facilities. This robust infrastructure supports efficient vaccine distribution, administration, and monitoring, ensuring high vaccination coverage and effectiveness.
   
• Furthermore, the region faces a high prevalence of swine diseases such as Porcine Reproductive and Respiratory Syndrome (PRRS) and Porcine Circovirus Type 2 (PCV2). The need to control these economically damaging diseases drives substantial growth of this market.
   

The U.S. swine vaccines market, which accounted for USD 583.6 million in 2023, is projected to reach USD 893.6 million by 2032.
 

• The U.S. is one of the largest pork producers and consumers globally. For instance, according to National Pork Board, the U.S. produces 11% of the world’s pork.
   
• This high demand for pork necessitates maintaining healthy swine herds. Producers adopt comprehensive vaccination programs to ensure consistent and high-quality meat production, driving swine vaccine market growth.
   

The swine vaccines market in China is set for remarkable growth in the coming years.
 

• There is a trend towards larger-scale swine farming operations in China, which are better equipped to implement comprehensive biosecurity measures and vaccination protocols.
   
• Modernized farms prioritize disease prevention to ensure consistent pork production, fueling the growth of market in China.
   

India is anticipated to grow at a considerable rate in the global swine vaccines market.
 

• India emerged as the 46th largest pig meat exporter globally in 2022, with exports totaling USD 3.75 million, as per OEC data. Key destinations for Indian pig meat shipments encompass Bhutan, Maldives, and Tanzania.
   
• As India strengthens its capabilities in swine vaccine production and disease management, there are potential export opportunities to neighboring countries and global markets. This enhances the market potential for Indian swine vaccine manufacturers, driving overall growth in the industry.